Literature DB >> 18713088

Preventive effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced lung injury in mice.

Shunji Tajima1, Manabu Soda, Masashi Bando, Munehiro Enomoto, Hideaki Yamasawa, Shoji Ohno, Toshinori Takada, Eiichi Suzuki, Fumitake Gejyo, Yukihiko Sugiyama.   

Abstract

BACKGROUND AND
OBJECTIVE: Reactive oxygen species (ROS) play an important role in the pathogenesis of acute lung injury (ALI) and pulmonary fibrosis. It was hypothesized that edaravone, a free radical scavenger, would be able to attenuate LPS-induced lung injury in mice by decreasing oxidative stress.
METHODS: For the in vivo experiments, lung injury was induced in female BALB/c mice by the intranasal instillation of LPS. Edaravone was given by intraperitoneal administration 1 h before the LPS challenge. For the in vitro experiments, MH-S cells (murine alveolar macrophage cell line) were exposed to edaravone, followed by stimulation with LPS.
RESULTS: In the LPS-induced ALI mouse model, the administration of edaravone attenuated cellular infiltration into and the concentrations of albumin, IL-6, tumour necrosis factor-alpha, keratinocyte-derived chemokine and macrophage inflammatory protein-2 in BAL fluid. In addition, the in vitro studies showed that the elevated IL-6 secretion from MH-S cells in response to LPS was significantly attenuated by co-incubation with edaravone.
CONCLUSIONS: In an experimental murine model, a free radical scavenger may prevent ALI via repression of pro-inflammatory cytokine production by lung macrophages.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18713088     DOI: 10.1111/j.1440-1843.2008.01322.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  5 in total

1.  Macrophages eliminate circulating tumor cells after monoclonal antibody therapy.

Authors:  Nuray Gül; Liane Babes; Kerstin Siegmund; Rianne Korthouwer; Marijn Bögels; Rens Braster; Gestur Vidarsson; Timo L M ten Hagen; Paul Kubes; Marjolein van Egmond
Journal:  J Clin Invest       Date:  2014-01-16       Impact factor: 14.808

2.  Beyond free radical scavenging: Beneficial effects of edaravone (Radicut) in various diseases (Review).

Authors:  Kiyoshi Kikuchi; Nobuyuki Takeshige; Naoki Miura; Yoko Morimoto; Takashi Ito; Salunya Tancharoen; Kei Miyata; Chiemi Kikuchi; Narumi Iida; Hisaaki Uchikado; Naohisa Miyagi; Naoto Shiomi; Terukazu Kuramoto; Ikuro Maruyama; Motohiro Morioka; Ko-Ichi Kawahara
Journal:  Exp Ther Med       Date:  2011-09-20       Impact factor: 2.447

3.  Erythropoietin Pretreatment Attenuates Seawater Aspiration-Induced Acute Lung Injury in Rats.

Authors:  Mu-Huo Ji; Jian-Hua Tong; Yuan-Hui Tan; Zhen-Yu Cao; Cong-Yang Ou; Wei-Yan Li; Jian-Jun Yang; Y G Peng; Si-Hai Zhu
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

4.  Edaravone Attenuated Particulate Matter-Induced Lung Inflammation by Inhibiting ROS-NF-κB Signaling Pathway.

Authors:  Yingying Zeng; Guiping Zhu; Mengchan Zhu; Juan Song; Hui Cai; Yuanlin Song; Jian Wang; Meiling Jin
Journal:  Oxid Med Cell Longev       Date:  2022-04-23       Impact factor: 7.310

5.  Inhibition of c-Jun N-terminal Kinase Signaling Pathway Alleviates Lipopolysaccharide-induced Acute Respiratory Distress Syndrome in Rats.

Authors:  Jian-Bo Lai; Chun-Fang Qiu; Chuan-Xi Chen; Min-Ying Chen; Juan Chen; Xiang-Dong Guan; Bin Ouyang
Journal:  Chin Med J (Engl)       Date:  2016-07-20       Impact factor: 2.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.